Back to Results
First PageMeta Content
Nitriles / Organofluorides / Prostate cancer / MDV3100 / Docetaxel / Testosterone / Abiraterone / Chemistry / Medicine / Organic chemistry


Medivation Contacts: Patrick Machado Chief Business & Financial Officer[removed]Astellas Contacts:
Add to Reading List

Document Date: 2012-08-15 20:23:03


Open Document

File Size: 69,15 KB

Share Result on Facebook

City

Tokyo / /

Company

New England Journal / Astellas Pharma Inc. / Mike Beyer Sam Brown Inc / Medivation Inc. / /

Event

FDA Phase / /

Facility

Memorial-Sloan Kettering Cancer Center / /

IndustryTerm

treatment of these diseases / biopharmaceutical / pharmaceuticals / pharmaceutical / /

MedicalCondition

advanced prostate cancer / metastatic castration-resistant prostate cancer / Seizure / fatigue / diseases / diarrhea / /

MedicalTreatment

chemotherapy / /

Organization

U.S. Food and Drug Administration / Memorial-Sloan Kettering Cancer Center / Genitourinary Oncology Service / Genitourinary Oncology Service at Memorial-Sloan Kettering Cancer Center / /

Person

Howard I. Scher / Genitourinary Oncology / Jenny Kite / Patrick Machado / /

/

Position

Chief Business & Financial Officer / co-principal investigator and lead author / leader in Oncology / Director / Investor Relations / chief / /

Product

testosterone / Enzalutamide / /

PublishedMedium

the New England Journal of Medicine / /

Technology

chemotherapy / DNA binding / /

URL

www.medivation.com / www.astellas.com/en / /

SocialTag